𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neurologic indications for therapeutic plasma exchange: An update

✍ Scribed by Kelly Gwathmey; Rasheed A. Balogun; Ted Burns

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
95 KB
Volume
26
Category
Article
ISSN
0733-2459

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Neurologists commonly use therapeutic plasma exchange (TPE, also known as plasmapheresis or therapeutic apheresis) to treat a number of conditions. This concise review examines the most common neurologic indications for therapeutic plasma exchange. It focuses on Guillain‐BarrΓ¨ syndrome and myasthenia gravis and also the role of TPE in chronic inflammatory demyelinating polyneuropathy, Lambert–Eaton syndrome, multiple sclerosis, neuromyelitis optica, paraproteinemic polyneuropathy, and Sydenham's chorea. As with any treatment, the proven efficacy, cost, side effects, and availability must be considered before initiation of therapy. J. Clin. Apheresis, 2011. Β© 2011 Wiley‐Liss, Inc.

πŸ“œ SIMILAR VOLUMES

Analysis of venous access for therapeuti
Analysis of venous access for therapeutic plasma exchange in patients with neurological disease
✍ J. E. Grishaber; M. C. Cunningham; P. A. Rohret; R. G. Strauss πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 446 KB

We retrospectively analyzed our 2-year experience with venous access for 363 therapeutic plasma exchanges in 46 patients with neurological disease, including acute Guillain-Barrd syndrome (N = 20). myasthenia gravis (N = 17), and chronic inHammatory demyelinating polyneuropathy (N = 9). Twenty-three

Therapeutic apheresis in neurological di
Therapeutic apheresis in neurological disorders: A survey of the evidence in support of current category I and II indications for therapeutic plasma exchange
✍ Robert Weinstein πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 87 KB

## Abstract Neurologic disorders constitute the largest group of indications for therapeutic plasma exchange. Although some of the traditional indications are supported by properly designed randomized trials, others are not. This article provides a critical look at the evidence in support of the as

Is therapeutic plasma exchange indicated
Is therapeutic plasma exchange indicated for patients with gemcitabine-induced hemolytic uremic syndrome?
✍ Ethan McCaleb Gore; Benjamin Scott Jones; Marisa B. Marques πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 76 KB

Atypical hemolytic uremic syndrome (aHUS) has been described as an uncommon complication of gemcitabine. In this review, we discuss the diagnosis of gemcitabine-induced aHUS (GiHUS) and the published experience with therapeutic plasma exchange (TPE). To illustrate GiHUS, we present a patient who dev

Partial colloid starch replacement for t
Partial colloid starch replacement for therapeutic plasma exchange
✍ Helen G. Owen; Mark E. Brecher πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 76 KB

Traditionally protein solutions have been used as the replacement solution of choice during therapeutic plasma exchange (TPE). Treatment protocols vary, but neurology patients, who exhibit autonomic instability, are typically replaced entirely with 5% protein solution. Due to sporadic product shorta